This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
15 Mar 2012

Bayer Sets Ambitious Targets for 2014

Sales of Bayer HealthCare are expected to reach approximately EUR 20 billion in 2014, while Bayer CropScience aims to raise sales to more than EUR 8 billion.

"In the life science areas – HealthCare and CropScience – we anticipate further increases in sales and margins through 2014,” said CEO Dr. Marijn Dekkers at the “Meet Management” investor conference last week in Leverkusen.

 

Sales of Bayer HealthCare are expected to reach approximately EUR 20 billion in 2014, while Bayer CropScience aims to raise sales to more than EUR 8 billion. Bayer MaterialScience intends to further strengthen its leading position in the market. This subgroup plans to achieve volume gains in excess of the rate of global GDP growth. Targets are based on the most recent currency assumptions, including an exchange rate of US$1.40 to the euro.

 

Dekkers said,“We believe four of our medicines in late-stage development have blockbuster potential

Related News